Cargando…
Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics
PURPOSES: The purposes of this study were to assess the correlation between the plasma level of Hsp90α and the clinicopathological characteristics of patients with liver cancer and compare the diagnostic efficacy of Hsp90α, AFP, CEA, and CA199 in HCC. EXPERIMENTAL DESIGN: A total of 200 individuals,...
Autores principales: | Han, Yueting, Zhang, Youqin, Cui, Lin, Li, Ze, Feng, Honglei, Zhang, Ying, Sun, Da, Ren, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340409/ https://www.ncbi.nlm.nih.gov/pubmed/34348726 http://dx.doi.org/10.1186/s12957-021-02269-4 |
Ejemplares similares
-
A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
por: Liu, Wei, et al.
Publicado: (2019) -
Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development
por: Wei, Wene, et al.
Publicado: (2021) -
Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial
por: Fu, Yan, et al.
Publicado: (2017) -
Diagnostic, clinicopathologic, therapeutic and prognostic value of Plasma Heat Shock Protein 90 levels in patients with advanced Gastrointestinal Carcinoma
por: Zhang, Yiyin, et al.
Publicado: (2020) -
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis
por: Ding, Qi, et al.
Publicado: (2022)